At a March 10 meeting on anesthesia in pediatric patients, the Food and Drug Administration concluded that information is insufficient to draw a definitive conclusion on the effects of anesthesia on cognitive function in young children, according to an ASA release.
The committee reviewed existing and in-progress clinical research before proceeding to discussion. In discussing the literature, the Committee emphasized there is a large imbalance between studies performed on animals (90 percent) and studies performed on humans (10 percent). The discrepancy makes it difficult to draw conclusions about risk levels for anesthesia in children.
Read the ASA release on the FDA meeting on pediatric anesthesia.
Read more on anesthesia:
-Changes to Epidural Doses Allow Movement Without Pain
-Anesthesiologist on the Move: Dr. Suwarna Bhide Deoskar Joins Essentia Health
-Drug Shortages Force California Facilities to Look for Alternatives
The committee reviewed existing and in-progress clinical research before proceeding to discussion. In discussing the literature, the Committee emphasized there is a large imbalance between studies performed on animals (90 percent) and studies performed on humans (10 percent). The discrepancy makes it difficult to draw conclusions about risk levels for anesthesia in children.
Read the ASA release on the FDA meeting on pediatric anesthesia.
Read more on anesthesia:
-Changes to Epidural Doses Allow Movement Without Pain
-Anesthesiologist on the Move: Dr. Suwarna Bhide Deoskar Joins Essentia Health
-Drug Shortages Force California Facilities to Look for Alternatives